Portfolio company
Nunabio
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops enzymatic technology for the synthesis of complex DNA sequences for customers in the biotechnology, pharmaceutical and materials science sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ribbon Bio
This company produces synthetic DNA molecules for research and development customers in the biotechnology and biopharmaceutical sectors.
Ansa Biotech
The company develops enzymatic DNA synthesis technology to provide complex genetic sequences for biopharmaceutical researchers and life science laboratories.
Ansa Biotechnologies
This company manufactures synthetic DNA using enzymatic synthesis technology for researchers in biological engineering, therapeutics, diagnostics and agriculture.
Molecular Assemblies
This company develops enzymatic DNA synthesis technology to provide long, high-quality oligonucleotides for researchers in synthetic biology, therapeutics, diagnostics and data storage.
EnPlusOne
This company develops enzymatic RNA synthesis technology for biotechnology firms and pharmaceutical manufacturers to produce oligonucleotides for therapeutic applications.
DNA Script
This company develops benchtop enzymatic DNA synthesis instruments for life science researchers and laboratories to produce synthetic nucleic acids on demand.
Dinya
Dinya develops enzymatic DNA synthesis technology to provide rapid, custom gene-length DNA sequences for healthcare researchers and pharmaceutical manufacturers.
Ribbon Biolabs
The company produces synthetic DNA molecules and assembly kits for biopharmaceutical researchers and synthetic biology organisations.
